Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial

References

• Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med. 2000;133(12):981–991. doi: 10.7326/0003-4819-133-12-200012190-00014.
   PubMed Web of Science ®Google Scholar
• Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):95s–103s. doi: 10.1378/chest.129.1_suppl.95S.
   PubMedGoogle Scholar
• Albert RH. Diagnosis and treatment of acute bronchitis. Am Fam Physician. 2010;82(11):1345–1350.
   PubMed Web of Science ®Google Scholar
• Kinkade S, Long NA. Acute bronchitis. Am Fam Physician. 2016;94(7):560–565.
   PubMed Web of Science ®Google Scholar
• Adams PF, Hendershot GE, Marano MA. Current estimates from the national health interview survey, 1996. Vital Health Stat. 1999;10(200):1–203.
   Google Scholar
• Lyu Y, Park S, Lee EJ, et al. A systemic review of clinical trials using medication for acute bronchitis: a pre-study on the development of traditional Korean medicine clinical practice guideline. J Korean Med. 2017;38(1):93–111. doi: 10.13048/jkm.17009.
   Google Scholar
• Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758–766. doi: 10.1001/jama.2009.1163.
   PubMed Web of Science ®Google Scholar
• Park S, Oh KC, Kim K-S, et al. Role of atypical pathogens and the antibiotic prescription pattern in acute bronchitis: a multicenter study in Korea. J Korean Med Sci. 2015;30(10):1446–1452. doi: 10.3346/jkms.2015.30.10.1446.
   PubMed Web of Science ®Google Scholar
• Kim W-Y, Park MJ, Rhee CK, et al. HL301 versus Umckamin in the treatment of acute bronchitis: a phase III, randomized, controlled, double-blind, multicenter study. Curr Med Res Opin. 2020;36(3):503–508. doi: 10.1080/03007995.2019.1706044.
   PubMed Web of Science ®Google Scholar
• Ra SW, Kim SY, Lim YY, et al. The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial. J Thorac Dis. 2021;13(1):1–9. doi: 10.21037/jtd-20-1567.
   PubMed Web of Science ®Google Scholar
• Matthys H, Eisebitt R, Seith B, et al. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine. 2003;10(Suppl 4):7–17. doi: 10.1078/1433-187x-00308.
   PubMed Web of Science ®Google Scholar
• Lee SW, Lyu YR, Kim SY, et al. Efficacy and safety of GHX02 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitis: a phase II, randomized, double-blind, placebo-controlled, multicenter trial. Front Pharmacol. 2021;12:761575. doi: 10.3389/fphar.2021.761575.
   PubMed Web of Science ®Google Scholar
• Yoon YY, Choi WS, Gil KC, et al. Mixture of ivy leaves and coptidis rhizoma suppresses pulmonary inflammation induced by air particles- and lipopolysaccharide-induced chronic obstructive pulmonary disease in mice. Yakhak Hoeji. 2019;63(2):95–102. doi: 10.17480/psk.2019.63.2.95.
   Google Scholar
• Chang SI, Ryu DY. Assessment of subchronic toxicity and toxicokinetics of AG NPP709 in Sprague-Dawley rats. J Ethnopharmacol. 2023;317:116801. doi: 10.1016/j.jep.2023.116801.
   PubMed Web of Science ®Google Scholar
• Lee EG, Rhee CK. The clinical efficacy of AG NPP709 (Synatura(®)) in patients with chronic bronchitis type stable chronic obstructive pulmonary disease. J Thorac Dis. 2020;12(5):2435–2442. doi: 10.21037/jtd.2020.03.61.
   PubMed Web of Science ®Google Scholar
• Hong G, Kim Y-I, Park SJ, et al. Effects of a mixture of ivy leaf extract and coptidis rhizome on patients with chronic bronchitis and bronchiectasis. Int J Environ Res Public Health. 2021;18(8):4024. doi: 10.3390/ijerph18084024.
   Web of Science ®Google Scholar
• Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. Explore. 2005;1(6):437–445. doi: 10.1016/j.explore.2005.08.009.
   Google Scholar
• Agbabiaka TB, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. Phytomedicine. 2008;15(5):378–385. doi: 10.1016/j.phymed.2007.11.023.
   PubMed Web of Science ®Google Scholar
• Kardos P, Lehrl S, Kamin W, et al. Assessment of the effect of pharmacotherapy in common cold/acute bronchitis – the Bronchitis Severity Scale (BSS). Pneumologie. 2014;68(8):542–546. doi: 10.1055/s-0034-1377332.
   PubMedGoogle Scholar
• Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. Curr Med Res Opin. 2007;23(2):323–331. doi: 10.1185/030079906X167318.
   PubMed Web of Science ®Google Scholar
• Matthys H, Lizogub VG, Malek FA, et al. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides. Curr Med Res Opin. 2010;26(6):1413–1422. doi: 10.1185/03007991003798463.
   PubMed Web of Science ®Google Scholar
• Völp A, Schmitz J, Bulitta M, et al. Ivy leaves extract EA 575 in the treatment of cough during acute respiratory tract infections: meta-analysis of double-blind, randomized, placebo-controlled trials. Sci Rep. 2022;12(1):20041. doi: 10.1038/s41598-022-24393-1.
   PubMedGoogle Scholar
• Greunke C, Hage-Hulsmann A, Sorkalla T, et al. A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the beta2-adrenergic responsiveness of human airway smooth muscle cells. Pulm Pharmacol Ther. 2015;31:92–98.
   PubMed Web of Science ®Google Scholar
• Song KJ, Shin YJ, Lee KR, et al. Expectorant and antitussive effect of Hedera helix and rhizoma coptidis extracts mixture. Yonsei Med J. 2015;56(3):819–824. doi: 10.3349/ymj.2015.56.3.819.
   PubMed Web of Science ®Google Scholar
• Lee C-D, Lee J-K, Jeong JH, et al. Inhibitory effects of an extract mixture of ivy (Hedera helix) leaves and coptidis rhizoma on ovalbumin-induced allergic lung inflammation by co-exposure to Asian sand dust in mice. Yakhak Hoeji. 2018;62(1):21–29. doi: 10.17480/psk.2018.62.1.21.
   Google Scholar
• Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (Hedera helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med. 2011;2011:382789–382789. doi: 10.1155/2011/382789.
   PubMed Web of Science ®Google Scholar
• Baharara H, Moghadam AT, Sahebkar A, et al. The effects of ivy (Hedera helix) on respiratory problems and cough in humans: a review. Adv Exp Med Biol. 2021;1328:361–376. doi: 10.1007/978-3-030-73234-9_23.
   PubMedGoogle Scholar
• Matthys H, Kamin W. Positioning of the Bronchitis Severity Score (BSS) for standardised use in clinical studies. Curr Med Res Opin. 2013;29(10):1383–1390. doi: 10.1185/03007995.2013.832183.
   PubMedGoogle Scholar